default author photo

Andrés Cervantes

INCLIVA Biomedical Research Institute

SCHOLARLY PAPERS

2

DOWNLOADS

206

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe. A Strategy Proposed by the LEGACy Consortium

Downloads 142 (521,245)

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe. A Strategy Proposed by the LEGACy Consortium

Number of pages: 15 Posted: 15 May 2024
Juan Antonio Carbonell-Asins, Elena Jiménez-Martí, Sergio Romero, Eduardo García-Galea, Beatriz Lopez, Carmelo Caballero, Hugo Boggino, Cinthia Gauna, Olga Beatriz Acevedo, Gabriel Benitez, Claudia Céspedes, Edith Fernandez-Figueroa, Nayeli Ortiz-Olvera, Erika Ruiz-García, Fátima Carneiro, Rita Barros, Ceu Figueiredo, Rui Ferreira, Tessa Suzanne Groen - van Schooten, Demi van Santvliet, Sarah Derks, Romina Luca, Maria Alsina, Arnoldo Riquelme, Andrés Cervantes and Tania Fleitas
INCLIVA Biomedical Research Institute, Universidad de Valencia, INCLIVA Biomedical Research Institute, Vall d'Hebron Institute of Oncology, Universidad de Valencia, Laboratorio Genpat, Laboratorio Genpat, Instituto de Previsión Social, Universidad Nacional de Asunción, Universidad Nacional de Asunción, Universidad Nacional de Asunción, Instituto Nacional de Medicina Genómica, Unidad Médica de Alta Especialidad Hospital de Especialidades "Dr. Bernardo Sepúlveda G" - Centro Médico Nacional Siglo XXI, Instituto Nacional de Cancerología, Universidade do Porto, Universidade do Porto, Universidade do Porto, Universidade do Porto, University of Amsterdam, University of Amsterdam, University of Amsterdam, Hospital Alexander Fleming, Vall d'Hebron Institute of Oncology (VHIO), Instituto de Salud Carlos III, INCLIVA Biomedical Research Institute and INCLIVA Biomedical Research Institute
Downloads 83 (792,223)

Abstract:

Loading...

Gastric cancer prevention, gastric cancer awareness, gastric cancer risk factors, gastric cancer symptoms, gastric cancer

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in Celac and Europe. A Strategy Proposed by the Legacy Consortium

Number of pages: 15 Posted: 18 Jun 2024
Juan Antonio Carbonell-Asins, Elena Jiménez-Martí, Sergio Romero, Eduardo García-Galea, Ana Miralles Marco, Beatriz Lopez, Carmelo Caballero, Hugo Boggino, Cinthia Gauna, Olga Beatriz Acevedo, Gabriel Benitez, Claudia Céspedes, Edith Fernandez-Figueroa, Nayeli Ortiz-Olvera, Erika Ruiz-García, Fátima Carneiro, Rita Barros, Ceu Figueiredo, Rui Ferreira, Tessa Suzanne Groen - van Schooten, Demi van Santvliet, Sarah Derks, Romina Luca, Maria Alsina, Arnoldo Riquelme, Andrés Cervantes and Tania Fleitas
INCLIVA Biomedical Research Institute, Universidad de Valencia, INCLIVA Biomedical Research Institute, Vall d'Hebron Institute of Oncology, Universidad de Valencia, Universidad de Valencia, Laboratorio Genpat, Laboratorio Genpat, Instituto de Previsión Social, Universidad Nacional de Asunción, Universidad Nacional de Asunción, Universidad Nacional de Asunción, Instituto Nacional de Medicina Genómica, Unidad Médica de Alta Especialidad Hospital de Especialidades "Dr. Bernardo Sepúlveda G" - Centro Médico Nacional Siglo XXI, Instituto Nacional de Cancerología, Universidade do Porto, Universidade do Porto, Universidade do Porto, Universidade do Porto, University of Amsterdam, University of Amsterdam, University of Amsterdam, Hospital Alexander Fleming, Vall d'Hebron Institute of Oncology (VHIO), Instituto de Salud Carlos III, INCLIVA Biomedical Research Institute and INCLIVA Biomedical Research Institute
Downloads 59 (996,491)

Abstract:

Loading...

Gastric cancer prevention, gastric cancer awareness, gastric cancer risk factors, gastric cancer symptoms, gastric cancer

2.

Phase 2 Study of Elraglusib (9-Ing-41), a Glycogen Synthase Kinase-3β Inhibitor, in Combination with Gemcitabine Plus Nab-Paclitaxel in Patients with Previously Untreated Metastatic Pancreatic Cancer

Number of pages: 40 Posted: 30 May 2024
Devalingam Mahalingam, Anwaar Saeed, Steven F. Powell, Marisol Huerta, Vaibhav Sahai, Andrew L. Coveler, Elizabeth J. Davis, Neeltje Steeghs, Mary Mulcahy, Alexander Raufi, Ludimila Cavalcante, Andrés Cervantes, Jordan Berlin, Taylor Weisskittel, Andrey Ugolkov, Andrew P. Mazar, William Mikrut, Sheri Smith, Francis J. Giles and Benedito A. Carneiro
affiliation not provided to SSRN, University of Kansas - Cancer Center, affiliation not provided to SSRN, INCLIVA Biomedical Research Institute, University of Michigan at Ann Arbor, Fred Hutchinson Cancer Research Center - Clinical Research Division, Vanderbilt University - Vanderbilt-Ingram Cancer Center, Netherlands Cancer Institute, Northwestern University - Northwestern Memorial Hospital, Brown University, Emory University - School of Medicine, INCLIVA Biomedical Research Institute, Vanderbilt University - Division of Hematology and Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Brown University
Downloads 64 (924,743)

Abstract:

Loading...

GSK-3β Inhibitor, elraglusib (9-ING-41), pancreatic cancer, combination, previously untreated